Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7316362

Concept 2024-03-01 to
2024-05-31
2023-03-01 to
2023-05-31
Consolidated statement of income
Statement of income
Net sales
35,810,000,000 JPY
32,096,000,000 JPY
Cost of sales
15,005,000,000 JPY
13,378,000,000 JPY
Operating expenses
Selling, general and administrative expenses
16,655,000,000 JPY
14,356,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
114,000,000 JPY
42,000,000 JPY
Net sales
Gross profit (loss)
20,804,000,000 JPY
18,718,000,000 JPY
Operating profit (loss)
4,149,000,000 JPY
4,361,000,000 JPY
Ordinary profit (loss)
5,562,000,000 JPY
5,713,000,000 JPY
Extraordinary income
1,354,000,000 JPY
JPY
Gain on disposal of non-current assets
2,000,000 JPY
JPY
Non-operating income
Dividend income
119,000,000 JPY
90,000,000 JPY
Interest income
728,000,000 JPY
470,000,000 JPY
Other
333,000,000 JPY
232,000,000 JPY
Non-operating income
1,562,000,000 JPY
1,413,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
4,000,000 JPY
0 JPY
Other
31,000,000 JPY
17,000,000 JPY
Non-operating expenses
149,000,000 JPY
61,000,000 JPY
Extraordinary losses
0 JPY
0 JPY
Loss on disposal of non-current assets
0 JPY
0 JPY
Profit (loss) before income taxes
6,915,000,000 JPY
5,712,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
1,352,000,000 JPY
JPY
Extraordinary losses
Income taxes
1,944,000,000 JPY
1,533,000,000 JPY
Profit (loss)
4,971,000,000 JPY
4,179,000,000 JPY
Profit (loss) attributable to non-controlling interests
182,000,000 JPY
129,000,000 JPY
Profit (loss) attributable to owners of parent
4,788,000,000 JPY
4,049,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,209,000,000 JPY
1,391,000,000 JPY
Foreign currency translation adjustment
5,919,000,000 JPY
995,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
3,000,000 JPY
-17,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-78,000,000 JPY
-46,000,000 JPY
Other comprehensive income
7,054,000,000 JPY
2,322,000,000 JPY
Profit attributable to
Comprehensive income
12,025,000,000 JPY
6,501,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,815,000,000 JPY
6,320,000,000 JPY
Comprehensive income attributable to non-controlling interests
209,000,000 JPY
181,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.